Aaron R Folsom1, Emily D Parker, Lisa J Harnack. 1. Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, Minnesota, USA. folsom@epi.umn.edu
Abstract
BACKGROUND: Guidelines to prevent and treat hypertension advocate the Dietary Approaches to Stop Hypertension (DASH) diet. METHODS: We studied whether a greater concordance with the DASH diet is associated with reduced incidence of hypertension (self-reported) and mortality from cardiovascular disease in 20,993 women initially aged 55 to 69 years. We created a DASH diet concordance score using food frequency data in 1986 and followed the women for events through 2002. RESULTS: No woman had perfect concordance with the DASH diet. Adjusted for age and energy intake, incidence of hypertension was inversely associated with the degree of concordance with the DASH diet, with hazard ratios across quintiles of 1.0, 0.91, 0.95, 0.99, and 0.87 (P trend = .02). There also were inverse, but not monotonic, associations between better DASH diet concordance and mortality from coronary heart disease, stroke, and all cardiovascular disease (CVD). However, after adjustment for other risk factors, there was little evidence that any end point was associated with the DASH diet score. CONCLUSIONS: Our results suggest that greater concordance with DASH guidelines did not have an independent long-term association with hypertension or cardiovascular mortality in this cohort. This implies that very high concordance, as achieved in the DASH trials, may be necessary to achieve any benefits of the DASH diet.
BACKGROUND: Guidelines to prevent and treat hypertension advocate the Dietary Approaches to Stop Hypertension (DASH) diet. METHODS: We studied whether a greater concordance with the DASH diet is associated with reduced incidence of hypertension (self-reported) and mortality from cardiovascular disease in 20,993 women initially aged 55 to 69 years. We created a DASH diet concordance score using food frequency data in 1986 and followed the women for events through 2002. RESULTS: No woman had perfect concordance with the DASH diet. Adjusted for age and energy intake, incidence of hypertension was inversely associated with the degree of concordance with the DASH diet, with hazard ratios across quintiles of 1.0, 0.91, 0.95, 0.99, and 0.87 (P trend = .02). There also were inverse, but not monotonic, associations between better DASH diet concordance and mortality from coronary heart disease, stroke, and all cardiovascular disease (CVD). However, after adjustment for other risk factors, there was little evidence that any end point was associated with the DASH diet score. CONCLUSIONS: Our results suggest that greater concordance with DASH guidelines did not have an independent long-term association with hypertension or cardiovascular mortality in this cohort. This implies that very high concordance, as achieved in the DASH trials, may be necessary to achieve any benefits of the DASH diet.
Authors: Laura P Svetkey; David W Harsha; William M Vollmer; Victor J Stevens; Eva Obarzanek; Patricia J Elmer; Pao Hwa Lin; Catherine Champagne; Denise G Simons-Morton; Mikel Aickin; Michael A Proschan; Lawrence J Appel Journal: Ann Epidemiol Date: 2003-07 Impact factor: 3.797
Authors: Lawrence J Appel; Michael W Brands; Stephen R Daniels; Njeri Karanja; Patricia J Elmer; Frank M Sacks Journal: Hypertension Date: 2006-02 Impact factor: 10.190
Authors: A R Folsom; L H Kushi; K E Anderson; P J Mink; J E Olson; C P Hong; T A Sellers; D Lazovich; R J Prineas Journal: Arch Intern Med Date: 2000-07-24
Authors: W M Vollmer; F M Sacks; J Ard; L J Appel; G A Bray; D G Simons-Morton; P R Conlin; L P Svetkey; T P Erlinger; T J Moore; N Karanja Journal: Ann Intern Med Date: 2001-12-18 Impact factor: 25.391
Authors: F M Sacks; L P Svetkey; W M Vollmer; L J Appel; G A Bray; D Harsha; E Obarzanek; P R Conlin; E R Miller; D G Simons-Morton; N Karanja; P H Lin Journal: N Engl J Med Date: 2001-01-04 Impact factor: 91.245
Authors: Lawrence J Appel; Catherine M Champagne; David W Harsha; Lawton S Cooper; Eva Obarzanek; Patricia J Elmer; Victor J Stevens; William M Vollmer; Pao-Hwa Lin; Laura P Svetkey; Sarah W Stedman; Deborah R Young Journal: JAMA Date: 2003 Apr 23-30 Impact factor: 56.272
Authors: E Obarzanek; F M Sacks; W M Vollmer; G A Bray; E R Miller; P H Lin; N M Karanja; M M Most-Windhauser; T J Moore; J F Swain; C W Bales; M A Proschan Journal: Am J Clin Nutr Date: 2001-07 Impact factor: 7.045
Authors: Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella Journal: Hypertension Date: 2003-12-01 Impact factor: 10.190
Authors: Claire T McEvoy; Tina Hoang; Stephen Sidney; Lyn M Steffen; David R Jacobs; James M Shikany; John T Wilkins; Kristine Yaffe Journal: Neurology Date: 2019-03-06 Impact factor: 9.910
Authors: Stephen P Juraschek; Lara C Kovell; Lawrence J Appel; Edgar R Miller; Frank M Sacks; Robert H Christenson; Heather Rebuck; Alexander R Chang; Kenneth J Mukamal Journal: Ann Intern Med Date: 2020-05-19 Impact factor: 25.391
Authors: Martha Clare Morris; Christy C Tangney; Yamin Wang; Frank M Sacks; David A Bennett; Neelum T Aggarwal Journal: Alzheimers Dement Date: 2015-02-11 Impact factor: 21.566
Authors: Heidi Wengreen; Ronald G Munger; Adele Cutler; Anna Quach; Austin Bowles; Christopher Corcoran; Joann T Tschanz; Maria C Norton; Kathleen A Welsh-Bohmer Journal: Am J Clin Nutr Date: 2013-09-18 Impact factor: 7.045
Authors: James A Blumenthal; Patrick J Smith; Stephanie Mabe; Alan Hinderliter; Kathleen Welsh-Bohmer; Jeffrey N Browndyke; Pao-Hwa Lin; William Kraus; P Murali Doraiswamy; James Burke; Andrew Sherwood Journal: Psychosom Med Date: 2017 Jul/Aug Impact factor: 4.312